SOCAR Trading announced the appointment of Klaus Lamprecht as its new managing director and senior products trader for North America. Lamprecht’s extensive experience in the energy sector, coupled with his decade-long tenure at SOCAR Group, positions him to significantly contribute to the company’s growth and expansion in the North American market.

Based in Houston, Lamprecht will assume overall leadership of SOCAR Trading’s North American operations. In this capacity, he will be responsible for developing and executing the company’s strategic vision for the region, overseeing all aspects of business development and ensuring the continued success of existing operations. His responsibilities will also encompass identifying and capitalising on emerging market opportunities, fostering strong relationships with key clients and partners, and managing the overall financial performance of the North American division.

Lamprecht’s career spans more than 24 years within the energy industry, encompassing a diverse range of roles and responsibilities. His expertise extends across various areas, including trading, marketing, operations, and strategic planning. This broad skillset and deep understanding of market dynamics will be instrumental in navigating the complexities of the North American energy landscape.

His appointment underscores SOCAR Trading’s commitment to building a strong and dynamic presence in North America. The company recognises the significant potential of the region and believes that Lamprecht’s leadership and experience will be crucial in realising that potential. His deep knowledge of the energy markets, combined with his proven track record of success, makes him ideally suited to lead SOCAR Trading’s North American operations into a new era of growth and expansion. The company anticipates that his contributions will strengthen relationships with existing clients, attract new business, and contribute to increased profitability and market share.

For more information visit www.socartrading.com

17th March 2025